This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BOOK BY MIDNIGHT SEPTEMBER 24 TO SAVE UP TO $500

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San Diego

Poster Presentation Hall

The deadline to submit an abstract and be included in the conference documentation is November 12, 2021 (full payment for conference and poster fee must be received by this date). After that date posters are on a space-available basis.

PLEASE NOTE: After November 12, 2021, poster space will be based on space availability only. You will be contacted after you submit your poster abstract below to let you know whether we will be able to accommodate it.
NB: Submitting an abstract below does not guarantee acceptance of your poster. Our team will aim to let you know if you have been accepted within 5 working days of submission.

Global Recognition of Your Research

Showcase your organization's latest research by presenting a poster in the poster presentation hall at Antibody Engineering & Therapeutics 2021, taking place in San Diego this December. Attending on a virtual pass? Get involved and showcase your research with your very own virtual poster room. This is a fantastic opportunity to put yourself in front of global big pharma representatives and antibody peers in the community.

In order to ensure we are able to include yours in the program, we will need your materials no later than midnight, Friday November 12, 2021. Please ensure that you have purchased a main conference pass prior with a poster presentation add-on. 

How to Participate

  • Register for an in-person or virtual experience pass with a poster presentation add-on (Register online here).
  • Once you have registered you will need to prepare an abstract that aligns with one of our topic streams, specified below.
  • Submit your poster abstract using this form.

As an in-person poster presenter, you can:

  • Meet with attendees on-site in the poster presentation hall and discuss your work
  • Showcase your research to big pharma representatives and other scientists in the field
  • Obtain exposure to key leaders in the antibody engineering and therapeutics landscape
  • Hold face-to-face meetings with attendees who visit your poster 
  • Post a PDF of your poster for in-person and virtual attendees to download
  • View both the in-person and virtual attendee list so you can connect with other attendees on the virtual conference platform

As a virtual poster presenter, you can:

  • Post a PDF of your poster for in-person and virtual attendees to download
  • Network with attendees virtually and obtain exposure to key leaders in the antibody engineering and therapeutics landscape
  • Showcase your research to big pharma representatives and other scientists in the field
  • Be a part of the virtual poster presentation area
  • View both the in-person and virtual attendee list so you can connect with other attendees on the virtual conference platform

**POSTER SPECIFICATIONS**

In-Person Poster: Poster must be printed by presenter and no larger than 48” high by 36” wide (Portrait).  
Note that all in-person poster presenters should also submit a digital poster following the specs below.
 
Digital Poster: Send your poster in a .PDF format with ideal resolution of 300 dpi to LSPOperations@informa.com no later then November 12.


POSTER TOPICS

  • Antibody Repertoires and COVID-19
  • Novel Therapeutic Targets and Non-Cancer Indications 
  • High-Throughput Antibody Discovery and Engineering: Driving Innovation Towards 0-Day Discovery
  • Engineering the Fc Region for Therapeutics
  • Vaccines and Antibodies to SARS-CoV-2: Dealing with Antigenic Variation
  • Intratumoral Immunotherapy Administration
  • Engineered Cytokines for Cancer Immunotherapy
  • Progression of Innovative Antibody-based Therapeutics to Clinical Stage
  • Antibody Library Design, Selection and Screening
  • Single Domain Antibodies, Repertoire, Engineering and Applications
  • Advances with CAR-effectors
  • Next Wave of Immuno-oncology Therapeutic Antibodies
  •  Innovative Targets for Antibody-based Therapies
  • Targeted Drug Conjugates
  • Machine Learning for Antibody and Protein Engineering
  • When High Affinity Is Necessary in Antibody Therapeutics